Celsion’s next generation vaccine delivers, on a single plasmid, multiple SARS-CoV-2 antigens in conjunction with a potent immune modifier, interleukin-12 (IL-12), which directs a TH-1 immune response, stimulates T-cell immunity, and also promises the promotion of humoral immunity (antibody response). Celsion has taken this multivalent approach in an effort to generate an even more robust immune response.
Keywords: Color, Information Graphics, Professional Education, Allergy / Immunology, Biotechnology, Cell biology / Histology, Disease Management, Mechanism of Action (MOA)
© Celsion